The NF-κB activation pathway: Its regulation and role in inflammation and cell survival

Cancer Journal from Scientific American

Volumn 4, Issue SUPPL. 1, 1998, Pages

  Karin, Michael ^a  

^a San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL;

EID: 0031816705     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Sen R, Baltimore D. Inducibility of the immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 1986;47:921-928.
2. Baeuerle PA, Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science 1988;242:540-546.
3. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-179.
4. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994;10:495-455.
5. Verma IM, Stevenson JK, Schwarz EM et al. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 1995;9:2723-2735.
6. Ghosh S, Gifford AM, Riviere LR et al. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 1990;62:1019-1029.
7. Ghosh G, Vanduyne G, Ghosh S et al. Structure of NF-κB p50 homodimer bound to a KB site. Nature 1995;373:303-310.
8. Muller CW, Rey FA, Sodeoka M et al. Structure of the NF-κB homodimer bound to DNA. Nature 1995;373:311-317.
9. Mercurio F, DiDonato J, Rosette C et al. p105 and p98 precursor proteins play an active role in NF-κB mediated signal transduction. Genes Dev 1993;7:705-718.
10. Rice NR, Mackichan ML, Israel A The precursor of NF-κB p50 has IκB-like functions. Cell 1992;78:773-785.
11. Beg AA, Baldwin AS Jr. The IκB proteins: multifunctional regulators of Rel/ NF-κB transcription factors. Genes Dev 1993; 7:2064-2070.
12. Haskill S, Beg AA, Tompkins SM et al. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 1991;65:1281-1289.
13. Thompson JE, Philips H, Erdjument-Bromage H et al. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 1995;80:573-582.
14. Alkalay I, Yaron A, Hatzubai A et al. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol Cell Biol 1995;15:1294-1301.
15. Brockman JA, Scherer DC, McKinsey TA et al. Coupling of a signal response domain in IκB to multiple pathways for NF-κB activation. Mol Cell Biol 1995;15:2809-2818.
16. Brown KA, Gerstberger S, Carlson L et al. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 1995;267:1485-1491.
17. Chen Z, Hagler J, Palombella VJ et al. Signal-induced site-specific phosphorylation targets IκB to the ubiquitin-proteasome pathway. Genes Dev 1995;9:1586-1597
18. DiDonato JA, Mercurio F, Karin M. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol Cell Biol 1995;15:1302-1311.
19. DiDonato JA, Mercurio F, Rosette C et al. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 1996;16:1295-1304.
20. Traenckner EB, Pahl HL, Henkel T et al. Phosphorylation of human IκB on serines 32 and 36 controls IκB proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 1995;14:2876-2883.
21. Palombella VJ, Rando OJ, Goldbert AL et al. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994;78:773-785.
22. Sun SC, Ganchi PA, Ballard DW et al. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 1993;259:1912-1915.
23. Beg AA, Sha WC, Bronson RT et al. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα -deficient mice. Genes Dev 1995;9:2736-2746.
24. DiDonato JA, Hayakawa AM, Rothwarf DM et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997;388:548-554.
25. Zandi E, Rothwarf D, Delhase M et al. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997;91:243-252.
26. Schulze-Osthoff K, Los M, Baeuerle PA Redox signaling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol 1995;50:735-741.
27. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071.
28. Dyer RB, Collaco CR, Niesel DW et al. Shigella flexneri invasion of HeLa cells induced NF-κB DNA binding activity. Infect Immunol 1993;61:4427-4433.
29. Mukaida N, Monta M, Ishikawa Y. Novel mechanism of glucocorticoid-mediated gene expression: NF-κB is target for glucorticoid-mediated IL-1B gene expression. J Biol Chem 1994; 269:13289-13295.
30. Nelson PJ, Kim HT, Manning WC et al. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993;151:2601-2612.
31. Ueda A, Okuda K, Shira A. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994;153:2052-2063.
32. Iaedemarco MF, McQuillan JJ, Rosen GD et al. Characterization of the promoter for vascular adhesion molecule-1 (VACM-1). J Biol Chem 1995;267:16323-16329.
33. van de Stolpe A, Caldenhoven E, Stade GB. 12-0-Tetradecanoyl phorbol-13-acetate and tumor necrosis factor alpha-mediated induction of intracellular adhesion molecule-1 is inhibited by dexamethasone: functional analysis of the human intercellular adhesion molecule-1 promoter. J Biol Chem 1994; 269:6185-6192.
34. Xie Q, Kashiwarbara Y, Nathan C. Rose of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-4708.
35. Yamamoto K, Arakawa T, Ueda N et al. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin 6 in the tumor necrosis-α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 1995;270:31315-31320.
36. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-959.
37. Auphan N, DiDonato JA, Rosette C et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-290.
38. Scheinman RI, Cogswell PC, Lofquist AK et al. Role of transcriptional activation of IκB in mediating immunosuppression by glucocorticoids. Science 1995;270:283-286.
39. Gonzalo JA, Gonzalez-Garcia A, Martinez C et al. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J Exp Med 1993;177:1239-1246.
40. Hamid Q, Springall DR, Riveros-Moreno V. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-1513.
41. Kharitonov SA, Yates D, Robbins RA et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-135.
42. Haddad EB, Salmon M, Koto H et al. Ozone induction of cytokine-induced neutrophil chemoattractant and nuclear factor-κB in rat lung. FEBS Lett 1996;379:265-268.
43. Adcock IM, Brown CR, Shirasaki H et al. Effects of dexamethasone on cytokine and phorbol ester stimulated c-Fos and c-Jun DNA binding and gene expression in human lung. Eur Res J 1994;7:2117-2123.
44. Schleimer RP, Bussie WW, O'Byrne PM, eds. Inhaled Glucocorticoids in Asthma. New York Marcel Dekker, 1997.
45. Handel ML, McMorrow LB, Gravallese EM. Nuclear factor-κB in rheumatoid synovium. Arthritis Rheum 1995;38:1762-1770.
46. Marok R, Winyaard PG, Coumbe A et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583-591.
47. Nishioka K, Sumida T, Hasunuma T. Human T lymphotropic virus type 1 in arthropathy and autoimmune disorders. Arthritis Rheum 1996;39:1410-1418.
48. Arent W, Dayer JM. Inhibition of the production and effects of IL-1 and TNF in rheumatoid arthritis. Arthritis Rheum 1995;38: 151-160.
49. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-1638.
50. McMurray RW. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum 1996;25:215-233.
51. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
52. van Antwerp DJ, Martin SJ, Kafri T et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996;274:787-789.
53. Beg AA, Sha WC, Bronson RT et al. Embryonic lethality and liver degeneration in mice lacking the RelA component in NF-κB. Nature 1995;376:167-169.
54. Liu Z-G, Hu H, Goeddel DV et al. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 1996;87:565-576.
55. Wang C-Y, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996;274:784-787.
56. Wu M, Lee H, Bellas RE et al. Inhibition of NF-KappaB/Rel induces apoptosis of murine B cells. EMBO J 1996;15:4682-4690.
57. Hsu H, Shu H, Pan MG et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308.
58. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995;81:495-504.
59. Boldin MP, Mett LL, Varfolemeev EE et al. Self-association of the "death domain" of the p55 tumor necrosis factor (TNF) receptor and Ras/APO1 prompts signaling for TNF and FAS/APO1 effects. J Biol Chem 1995;270:387-391.
60. Chinnaiyan AM, O'Rourke K, Tewari M et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
61. Hsu H, Huang J, Shu HB et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996;4:387-396.
62. Greenfeder SA, Varnell T, Powers G et al. Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. J Biol Chem 1995;270:22460-22466.
63. Cao Z, Henzel WJ, Gao X IRAK: a kinase associated with the interleukin-1 receptor. Science 1996;271:1128-1131.
64. Cao Z, Xiong J, Takeuchi M et al. TRAF6 is a signal transducer for interkeukin-1. Nature 1996;383:443-446.
65. Malinin NL, Boldin MP, Kovalenko AV et al. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 1997;385:540-544.
66. Régnier CH, Yeong Song H, Gao X et al. Identification and characterization of an IκB kinase. Cell 1997;90:373-383.
67. Haystead CM, Gregory P, Sturgill TW et al. γ-Phosphate-linked ATP-sepharose for the affinity purification of protein kinases: rapid purification to homogeneity of skeletal muscle mitogen-activated protein kinase kinase. Eur J Biochem 1993;214:459-467.
68. Connelly MA, Marcu KB. CHUK, a new member of the helixloop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain. Cell Mol Biol Res 1995;41:537-549.
69. Taylor SS, Knighton DR, Zheng J et al. Structural framework for the protein kinase family. Annu Rev Cell Biol 1992;8:429-462.
70. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.
71. Lee FS, Hagler J, Chen ZJ et al. Activation of the IκB alpha kinase complex by MEDD1, a kinase of the JNK pathway. Cell 1997; 88:213-222.
72. Natoli G, Costanzo A, Moretti F et al. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2: nuclear factot kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J Biol Chem 1997;272:26079-26082.
73. Song HY, Régnier CJ, Kirschning CJ et al. TNF-mediated kinase cascades: bifurcation of NF-κB and JNK/SAPK pathways at TRAF2. Proc Nad Acad Sci USA 1997;94:9792-9796.
74. Spencer DM, Wandless TJ, Schreiber SL et al. Controlling signal transduction with synthetic ligands. Science 1993;262:1019-1024.